As of 2025-07-16, the Gross Margin of Beijing Hotgen Biotech Co Ltd (688068.SS) is 49.7%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-12-31 | 49.7% |
2023-12-31 | 60.9% |
2022-12-31 | 50.3% |
2021-12-31 | 58% |
2020-12-31 | 63% |
2019-12-31 | 73.1% |
2018-12-31 | 73.8% |
2017-12-31 | 74.1% |
2016-12-31 | 76% |
- |